Early adverse changes in liver microvascular circulation during experimental septic shock are not linked to an absolute nitric oxide deficit

Microvascular Research

Volumn 90, Issue , 2013, Pages 187-191

  Morel, JérÔme ^a,b   Li, Jacques Yuan ^c   Eyenga, Pierre ^b   Meiller, Anne ^c   Gustin, Marie Paule ^c   Bricca, Giampiero ^c   Molliex, Serge ^a   Viale, Jean Paul ^b,d,e  

^a UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^b University Lyon 1   (France)

^c UNIVERSITÉ LYON 1   (France)

^d UNIVERSITÉ DE LYON   (France)

^e CROIX ROUSSE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; ISOPROTEIN; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CECUM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ELECTRODE; LASER DOPPLER FLOWMETRY; LIGATION; LIVER BLOOD FLOW; MALE; MICROCIRCULATION; NONHUMAN; PERFUSION; PERITONITIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PUNCTURE; RAT; SEPTIC SHOCK; SHAM PROCEDURE;

ANIMALIA; RATTUS;

CECAL LIGATION AND PUNCTURE; CLP; MESSENGER RNA; MRNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NO; NOS; REAL-TIME POLYMERASE CHAIN REACTION; RT-PCR;

ANIMALS; BLOOD FLOW VELOCITY; CECUM; DISEASE MODELS, ANIMAL; LASER-DOPPLER FLOWMETRY; LIGATION; LIVER; LIVER CIRCULATION; MALE; MICROCIRCULATION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PUNCTURES; RATS; RATS, WISTAR; RNA, MESSENGER; SHOCK, SEPTIC; TIME FACTORS;

EID: 84888433020     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.07.005     Document Type: Article

References (25)

1. Almond N.E., Wheatley A.M. Measurement of hepatic perfusion in rats by laser Doppler flowmetry. Am. J. Physiol. 1992, 262:G203-G209.
2. Archer S. Measurement of nitric oxide in biological models. FASEB J. 1993, 7:349-360.
3. Boerma E.C., et al. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Crit. Care Med. 2010, 38:93-100.
4. Brealey D., et al. Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 2002, 360:219-223.
5. Bultinck J., et al. Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J. 2006, 20:2363-2365.
6. Buwalda M., Ince C. Opening the microcirculation: can vasodilators be useful in sepsis?. Intensive Care Med. 2002, 28:1208-1217.
7. De Backer D., et al. Microvascular blood flow is altered in patients with sepsis. Am. J. Respir. Crit. Care Med. 2002, 166:98-104.
8. Dyson A., Singer M. Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?. Crit. Care Med. 2009, 37:S30-S37.
9. Eyenga P., et al. Time course of liver nitric oxide concentration in early septic shock by cecal ligation and puncture in rats. Nitric Oxide 2010, 23:194-198.
10. Gundersen Y., et al. The nitric oxide donor sodium nitroprusside protects against hepatic microcirculatory dysfunction in early endotoxaemia. Intensive Care Med. 1998, 24:1257-1263.
11. Ince C. The microcirculation is the motor of sepsis. Crit. Care 2005, 9(Suppl. 4):S13-S19.
12. Kollmar O., et al. Portal branch ligation induces a hepatic arterial buffer response, microvascular remodeling, normoxygenation, and cell proliferation in portal blood-deprived liver tissue. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G1534-G1542.
13. Lam C., et al. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J. Clin. Invest. 1994, 94:2077-2083.
14. Levy M.M., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit. Care Med. 2003, 31:1250-1256.
15. Lhuillier F., et al. Hepatic ischemia is associated with an increase in liver parenchyma nitric oxide that is in part enzyme-independent. Anesthesiology 2003, 98:373-378.
16. Lopez A., et al. Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med. 2004, 32:21-30.
17. Lush C.W., Kvietys P.R. Microvascular dysfunction in sepsis. Microcirculation 2000, 7:83-101.
18. Okamoto I., et al. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am. J. Respir. Crit. Care Med. 2000, 162:716-722.
19. Remick D.G., Ward P.A. Evaluation of endotoxin models for the study of sepsis. Shock 2005, 24(Suppl. 1):7-11.
20. Siegemund M., et al. The NO donor SIN-1 improves intestinal-arterial P(CO(2)) gap in experimental endotoxemia: an animal study. Acta Anaesthesiol. Scand. 2007, 51:693-700.
21. Suematsu M., et al. Mechanistic probing of gaseous signal transduction in microcirculation. Antioxid. Redox Signal. 2003, 5:485-492.
22. Tawadrous M.N., et al. Microvascular origin of laser-Doppler flux signal from the surface of normal and injured liver of the rat. Microvasc. Res. 2001, 62:355-365.
23. Trzeciak S., et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Ann. Emerg. Med. 2007, 49:88-98.
24. Zhang X. Real time and in vivo monitoring of nitric oxide by electrochemical sensors-from dream to reality. Front. Biosci. 2004, 9:3434-3446.
25. Zhou M., et al. Endothelial nitric oxide synthase is downregulated during hyperdynamic sepsis. Biochim. Biophys. Acta 1997, 1335:182-190.